IkappaB
Author:
Niederberger Ellen
Reference46 articles.
1. Albertella, M. R., & Campbell, R. D. (1994). Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins. Human Molecular Genetics, 3(5), 793–799. 2. Baeuerle, P. A., & Baltimore, D. (1988). I kappa B: A specific inhibitor of the NF-kappa B transcription factor. Science, 242(4878), 540–546. 3. Cho, M. K., Park, J. W., Jang, Y. P., Kim, Y. C., & Kim, S. G. (2002). Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappaBalpha phosphorylation and of p65 nuclear translocation in macrophages. International Immunopharmacology, 2(1), 105–116. [pii] S1567-5769(01)00153-9. 4. DiDonato, J., Mercurio, F., Rosette, C., Wu-Li, J., Suyang, H., Ghosh, S., et al. (1996). Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Molecular and Cellular Biology, 16(4), 1295–1304. 5. Fiorini, E., Schmitz, I., Marissen, W. E., Osborn, S. L., Touma, M., Sasada, T., et al. (2002). Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitor. Molecular Cell, 9(3), 637–648. [pii] S1097276502004690.
|
|